Prevention of NSAID-Enteropathy: A Soluble Problem?

Digestive Diseases and Sciences

Volumn 61, Issue 1, 2016, Pages 1-3

  Wallace, John L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTAN; INDOMETACIN; MANNAN; NONSTEROID ANTIINFLAMMATORY AGENT; PECTIN; PLANT GUM;

ADMINISTRATION AND DOSAGE; ANIMAL; ARTHRITIS, EXPERIMENTAL; DIETARY FIBER; DRUG EFFECTS; INTESTINE MUCOSA; JOINT; MALE; SMALL INTESTINE; ULCER;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; DIETARY FIBER; GALACTANS; INDOMETHACIN; INTESTINAL MUCOSA; INTESTINE, SMALL; JOINTS; MALE; MANNANS; PECTINS; PLANT GUMS; ULCER;

EID: 84952983859     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-015-3963-7     Document Type: Editorial

References (17)

1. Lanas A, Sopena F. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications. Gastroenterol Clin North Am. 2009;38:333–352.
2. Lanas A, Garcıa-Rodrıguez LA, Polo-Tomas M, et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol. 2009;104:1633–1641.
3. Wallace JL. Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy. World J Gastroenterol. 2013;19:1861–1876.
4. Wallace JL, Syer S, Denou E, et al. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology. 2011;141:1314–1322.
5. Satoh H, Amagase K, Takeuchi K. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility. J Pharmacol Exp Ther. 2012;343:270–277.
6. Blackler RW, De Palma G, Manko A, et al. Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID. Am J Physiol Gastrointest Liver Physiol. 2015;308:G994–G1003.
7. Watanabe T, Tanigawa T, Nadatani Y, et al. Risk factors for severe nonsteroidal anti-inflammatory drug-induced small intestinal damage. Dig Liver Dis. 2013;45:390–395.
8. Watanabe T, Nishio H, Tanigawa T, et al. Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid. Am J Physiol Gastrointest Liver Physiol. 2009;297:G506–G513.
9. Syer SD, Blackler RW, Martin R, et al. NSAID enteropathy and bacteria: a complicated relationship. J Gastroenterol. 2015;50:387–393.
10. Lanas A, Scarpignato C. Microbial flora in NSAID-induced intestinal damage: a role for antibiotics? Digestion. 2006;73:136–150.
11. Satoh H, Matsumoto H, Hirakawa T, Wada N. Soluble dietary fibers can protect the small intestinal mucosa without affecting the anti-inflammatory effect of indomethacin in adjuvant-induced arthritis rats. Dig Dis Sci. (Epub ahead of print). doi:10.1007/s10620-015-3889-0.
12. Licht TR, Hansen M, Bergstrom A, et al. Effects of apples and specific apple components on the cecal environment of conventional rats: role of apple pectin. BMC Microbiol. 2010;10:13.
13. Ohashi Y, Sumitani K, Tokunaga M, Ishihara N, Okubo T, Fujisawa T. Consumption of partially hydrolysed guar gum stimulates Bifidobacteria and butyrate-producing bacteria in the human large intestine. Benef Microbes. 2015;6:451–455.
14. Akiba Y, Inoue T, Kaji I, et al. Short-chain fatty acid sensing in rat duodenum. J Physiol. 2015;593:585–599.
15. Inoue T, Higashiyama M, Kaji I, et al. Dipeptidyl peptidase IV inhibition prevents the formation and promotes the healing of indomethacin-induced intestinal ulcers in rats. Dig Dis Sci. 2014;59:1286–1295.
16. Kritchevsky D. Influence of dietary fiber on bile acid metabolism. Lipids. 1978;13:982–985.
17. Roberfroid M, Gibson GR, Hoyles L, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr. 2010;104:S1–S63.